skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Pseudonymization of patient identifiers for translational research

BMC medical informatics and decision making, 2013-07, Vol.13 (1), p.75-75, Article 75 [Peer Reviewed Journal]

COPYRIGHT 2013 BioMed Central Ltd. ;2013 Aamot et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright © 2013 Aamot et al.; licensee BioMed Central Ltd. 2013 Aamot et al.; licensee BioMed Central Ltd. ;ISSN: 1472-6947 ;EISSN: 1472-6947 ;DOI: 10.1186/1472-6947-13-75 ;PMID: 23883409

Full text available

Citations Cited by
  • Title:
    Pseudonymization of patient identifiers for translational research
  • Author: Aamot, Harald ; Kohl, Christian Dominik ; Richter, Daniela ; Knaup-Gregori, Petra
  • Subjects: Analysis ; Anonyms and Pseudonyms ; Communication ; Computer Security ; Confidentiality - standards ; Ethical aspects ; Genetics, Medical - methods ; Genetics, Medical - standards ; Genomics - ethics ; Genomics - standards ; Humans ; Information Storage and Retrieval - methods ; Information Storage and Retrieval - standards ; Medical care ; Medical records ; Patient Identification Systems - methods ; Patients' rights ; Privacy - legislation & jurisprudence ; Safety and security measures ; Technical Advance ; Technology Assessment, Biomedical ; Translational Medical Research ; Translational research ; Warehousing ; Work Simplification
  • Is Part Of: BMC medical informatics and decision making, 2013-07, Vol.13 (1), p.75-75, Article 75
  • Description: The usage of patient data for research poses risks concerning the patients' privacy and informational self-determination. Next-generation-sequencing technologies and various other methods gain data from biospecimen, both for translational research and personalized medicine. If these biospecimen are anonymized, individual research results from genomic research, which should be offered to patients in a clinically relevant timeframe, cannot be associated back to the individual. This raises an ethical concern and challenges the legitimacy of anonymized patient samples. In this paper we present a new approach which supports both data privacy and the possibility to give feedback to patients about their individual research results. We examined previously published privacy concepts regarding a streamlined de-pseudonymization process and a patient-based pseudonym as applicable to research with genomic data and warehousing approaches. All concepts identified in the literature review were compared to each other and analyzed for their applicability to translational research projects. We evaluated how these concepts cope with challenges implicated by personalized medicine. Therefore, both person-centricity issues and a separation of pseudonymization and de-pseudonymization stood out as a central theme in our examination. This motivated us to enhance an existing pseudonymization method regarding a separation of duties. The existing concepts rely on external trusted third parties, making de-pseudonymization a multistage process involving additional interpersonal communication, which might cause critical delays in patient care. Therefore we propose an enhanced method with an asymmetric encryption scheme separating the duties of pseudonymization and de-pseudonymization. The pseudonymization service provider is unable to conclude the patient identifier from the pseudonym, but assigns this ability to an authorized third party (ombudsman) instead. To solve person-centricity issues, a collision-resistant function is incorporated into the method. These two facts combined enable us to address essential challenges in translational research. A productive software prototype was implemented to prove the functionality of the suggested translational, data privacy-preserving method. Eventually, we performed a threat analysis to evaluate potential hazards connected with this pseudonymization method. The proposed method offers sustainable organizational simplification regarding an ethically indicated, but secure and controlled process of de-pseudonymizing patients. A pseudonym is patient-centered to allow correlating separate datasets from one patient. Therefore, this method bridges the gap between bench and bedside in translational research while preserving patient privacy. Assigned ombudsmen are able to de-pseudonymize a patient, if an individual research result is clinically relevant.
  • Publisher: England: BioMed Central Ltd
  • Language: English
  • Identifier: ISSN: 1472-6947
    EISSN: 1472-6947
    DOI: 10.1186/1472-6947-13-75
    PMID: 23883409
  • Source: SpringerOpen
    DOAJ Directory of Open Access Journals
    Geneva Foundation Free Medical Journals at publisher websites
    MEDLINE
    PubMed Central
    ROAD: Directory of Open Access Scholarly Resources
    ProQuest Central

Searching Remote Databases, Please Wait